Jupiter Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Jupiter Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-979,648	Closed	-$1.98M	–	452
2022 Q3	$1.98M	Sell	979,648 -7,630	-0.8%	-$21.4K	0.03%	347
2022 Q2	$3.14M	Sell	987,278 -3,576	-0.4%	-$13K	0.04%	306
2022 Q1	$4.12M	Buy	990,854 +31,719	+3%	+$140K	0.05%	279
2021 Q4	$4.66M	Buy	959,135 +114,500	+14%	+$571K	0.05%	277
2021 Q3	$4.5M	Sell	844,635 -32,621	-4%	-$164K	0.05%	272
2021 Q2	$4.49M	Buy	877,256 +181,139	+26%	+$1.03M	0.05%	314
2021 Q1	$4.68M	Buy	+696,117	New	+$3.86M	0.05%	327

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Asset Management's AMRX Position: Q4 2022 in Review

Jupiter Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q4 2022, closing a stake of 979,648 shares — an estimated $1.98M sold.

Jupiter Asset Management first reported a position in AMRX in Q1 2021 and held it in 7 quarters. The position peaked at $4.68M in Q1 2021. 156 funds tracked by Wall St. Rank hold AMRX as of Q4 2022.

Jupiter Asset Management reported no remaining Amneal Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Jupiter Asset Management sold 979,648 Amneal Pharmaceuticals shares in Q4 2022, an estimated $1.98M.
Jupiter Asset Management first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 7 quarters.
Jupiter Asset Management's Amneal Pharmaceuticals position peaked at $4.68M in Q1 2021.
156 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2022.

Based on Jupiter Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.